Screening for Bacterial Vaginosis at the Time of Intrauterine Contraceptive Device Insertion: Is There a Role?

Journal of Obstetrics and Gynaecology Canada

Volumn 34, Issue 2, 2012, Pages 179-185

  Alice, T N D ^a   Kives, Sari ^b   Merovitz, Lisa ^c   Nitsch, Romy ^d   Tessler, Karen ^b   Yudin, Mark H ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MARY S HOSPITAL   (Canada)

^d KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

Bacterial; Cohort studies; Complications; Intrauterine devices; Vaginosis

Indexed keywords

LEVONORGESTREL; METRONIDAZOLE;

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; ETHNICITY; FEMALE; FISHER EXACT TEST; FOLLOW UP; HUMAN; INCIDENCE; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MIDDLE AGED; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PELVIC EXAMINATION; PREVALENCE; SCREENING TEST; STUDENT T TEST; VAGINITIS; YOUNG ADULT; ADOLESCENT; FEVER; INTRAUTERINE DEVICE EXPULSION; PAIN; UTERUS BLEEDING;

ADOLESCENT; ADULT; FEMALE; FEVER; HUMANS; INTRAUTERINE DEVICE EXPULSION; INTRAUTERINE DEVICES; MIDDLE AGED; PAIN; UTERINE HEMORRHAGE; VAGINOSIS, BACTERIAL;

EID: 84861811606     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)35161-1     Document Type: Article

References (29)

1. Morris M., Dunn S., Fisher W.A., Rowe T., Black A., Francoeur D., Rowe T. Introduction.In:Contraception Guidelines Committee.Canadian contraception consensus: SOGC Clinical Practice Guidelines,No 143. J Obstet Gynaecol Can 2004, 26(3):145. Chapter 1:February 2004 Pt 1.
2. World Health Organization. Medical eligibility criteria for contraceptive use, 4th ed., 2009. Geneva: WHO; 2010.
3. Gareen I.F., Greenland S., Morgenstern H. Intrauterine devices and PID: meta-analyses of published studies 1974-1990. Epidemiology 2000, 11:589-597.
4. Farley T.M., Rosenberg M.J., Rowe P.J., Chen J.H., Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992, 339:785-788.
5. Walsh T., Grimes D., Frezieres R., Nelson A., Bernstein L., Coulson A., et al. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices IUD Study Group. Lancet 1998, 351:1005-1008.
6. Ferraz do Lago R., Simões J., Bahamondes L., Camargo P.S., Perrotti M., Monteiro I. Follow-up of users of intrauterine device with and without BV and other cervicovaginal infections. Contraception 2003, 60:105-109.
7. Sobel J. Bacterial vaginosis. UptoDate January 2007 2007, Available at, Accessed June 28. http://www.utdol.com/utd/content/topic.do?topicKey=gen_gyne/27221&view=print.
8. Allsworth J.E., Peipert J.F. Prevalence of BV: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007, 109:114-120.
9. Black A., Fleming F., Pymar H., Brown T., Smith T., Black A., Francoeur D., Rowe T. Intrauterine devices. In:Contraception Guidelines Committee. Canadian contraception consensus: SOGC Clinical Practice Guidelines, No 143. J Obstet Gynaecol Can 2004, 26(3):248-251. Chapter 4:March 2004 Pt 2.
10. Andrews W.W., Hauth J.C., Cliver S.P., Conner M.G., Goldenberg R.L., Goepfert A.R. Association of asymptomatic bacterial vaginosis with endometrial microbial colonization and plasma cell endometritis in nonpregnant women. Am J Obstet Gynecol 2006, 195:1611-1616.
11. Oleen-Burkey M.A., Hillier S.L. Pregnancy complications associated with bacterial vaginosis and their estimated costs. Infect Dis Obstet Gynecol 1995, 3:149-157.
12. MacDermott RI. Bacterial vaginosis. Br J Obstet Gynecol 1995, 102:92-94.
13. Martin H.L., Richardson B.A., Nyange P.M., Lavreys L., Hillier S.L., Chohan B., et al. Vaginal lactobacilli, microbial flora and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999, 180:1863-1868.
14. Myer L., Demy L., Telerant R., Souza M., Wright T.C., Kuhn L. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis 2005, 192:1372-1380.
15. Cherpes T.L., Meyn L.A., Krohn M.A., Lurie J.G., Hillier S.L. Association between acquisition of herpes simplex virus type 2 in women and BV. Clin Infect Dis 2003, 37:319-325.
16. Wiesenfeld H.C., Hillier S.L., Krohn M.A., Landers D.V., Sweet R.L. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 2003, 36:663-668.
17. Nugent R.P., Krohn M.A., Hillier SL. Reliability of diagnosis of bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991, 29:297-301.
18. Schwebke J.R., Hillier S.L., Sobel J.D., McGregor J.A., Sweet RL. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol 1996, 88:573-576.
19. Lang T.A., Secic M. How to report statistics in medicine 2006, American College of Physicians, Philadelphia.
20. Joesoef M.R., Karundeng A., Runtupalit C., Moran J.S., Lewis J.S., Ryan C.A., et al. High rate of bacterial vaginosis among women with intrauterine devices in Manado 2001, 64:169-172. Indonesia Contraception.
21. Ness R.B., Hillier S.L., Kip K.E., Soper D.E., Stamm C.A., McGregor J.A., et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 2004, 104:761-769.
22. McDonald H., Brocklehurst P., Parsons J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2005, CD000262.
23. Hodoglugil N.N., Aslan D., Bertan M. Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence. Contraception 2000, 61:359-364.
24. Demirezen S., Kuguk A., Beksag M.S. The association between copper containing IUCD and BV. Cent Eur J Public Health 2006, 14:138-140.
25. Ceruti M., Canestrelli M., Condemi V., Piantelli G., De Paolis P., Amone F., et al. Methods of contraception and rates of genital infections. Clin Exp Obstet Gynecol 1994, 21:119-123.
26. Roy S. Nonbarrier contraceptives and vaginitis and vaginosis. Am J Obstet Gynecol 1991, 165(4):1240-1244. Pt 2.
27. Avonts D., Sercu M., Heyerick P., Vandermeeren I., Meheus A., Piot P. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sex Transm Dis 1990, 17:23-29.
28. Krishna A., Usha S., Veena A. Microbial and cytopathological study of intrauterine contraceptive device users. Indian J Med Sci 2004, 58:394-399.
29. Neale R., Knight I., Keane F. Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?. Int J STD AIDS 2009, 20:423-424.